Ariad Pharmaceuticals (ARIA) Posts Q2 Loss of 36c; Revs Light
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $23.99 --0%
Financial Fact:
Net income (loss) per share - basic: -0.14
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Net income (loss) per share - basic: -0.14
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) reported Q2 loss of ($0.36), $0.18 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $66 thousand versus the consensus estimate of $930 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance
- Northeast Community Bancorp, Inc. (NECB) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
